Duopharma to supply 6.4 million doses of Sputnix V vaccine 


KUALA LUMPUR: Duopharma Biotech Bhd has entered into a deal to supply the Ministry of Health with 6.4 million doses of Covid-19 vaccine developed by Russia.

The supply is subject to the “Sputnik V” vaccine being approved by Drug Control Authority, Malaysia through technical evaluation by the National Pharmaceutical Regulatory Agency.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Duopharma Biotech , vaccine , Sputnix V

Next In Business News

Gas Malaysia reports lower 2Q26 earnings
Infomina to acquire 51% stake in Blue Fortress for RM25.5mil
BM Greentech unit inks MOU with QL Nutrifood, Synbio Power for SPV collaboration
Midtown Group secures RM73.34mil variation order
SRKK AI to acquire five Klang office units for RM1.61mil
Bintai Kinden secures tender for 103-acre Ayer Keroh land
Alam Maritim group CEO Azmi Ahmad released from MACC remand
Affin, BCA forge strategic partnership to boost cross-border customer benefits
TH Plantations records net profit of RM5.78mil in 2Q26
reNIKOLA secures long-term gas sales agreement in Indonesia

Others Also Read